ELTP OTC
Elite Pharmaceuticals, Inc.
1W: -11.4%
1M: -17.2%
3M: -37.6%
YTD: -54.3%
1Y: -65.6%
3Y: +154.1%
5Y: +357.3%
$0.23
+0.00 (+0.73%)
Weekly Expected Move ±6.3%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$149M
Revenue
+77.1% YoY
$45M
Net Income
+1140.0% YoY
$23M
Free Cash Flow
+362.9% YoY
50.1%
Gross Margin
27.1%
Op. Margin
45.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE58.9%
ROA38.2%
ROIC-0.1%
Valuation
P/E4.6
P/B2.4
EV/EBITDA-787.9
Leverage
Debt/Equity0.06
Current Ratio6.45
Interest Cov.89.3x
Quality Scores
Piotroski F6/9
Altman Z7.92
Beneish M-150.44